Paraneoplastic Neurologic Syndromes Associated With Merkel Cell Carcinoma

Archive ouverte

Ciano-Petersen, Nicolás Lundahl | Muñiz-Castrillo, Sergio | Villagrán-García, Macarena | Farina, Antonio | Vogrig, Alberto | Wucher, Valentin | Duy, Le | Birzu, Cristina | Goncalves, David | Flabeau, Olivier | Duwicquet, Coline | Benard, Adrien | Nicole, Fabien | Rogemond, Veronique | Picard, Geraldine | Joubert, Bastien | Honnorat, Jerome

Edité par CCSD ; American Academy of neurology -

International audience.

Background and Objectives

To define the clinical and immunologic profile of patients with paraneoplastic neurologic syndromes (PNSs) associated with Merkel cell carcinoma (MCC).

Methods

Retrospective analysis was conducted on patients with suspected MCC-related PNS assessed at the French Reference Center, and cases were identified by a systematic review of the literature (MEDLINE, Embase) following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Results

A total of 17 patients were identified in our center and 30 in the systematic review, resulting in an overall cohort of 47 patients. The median age was 65 years (range 41-90), and 30 of 46 (65%) were men. Lambert-Eaton myasthenic syndrome (LEMS) (14/47, 29%), rapidly progressive cerebellar syndrome (11/47, 23%), and encephalomyelitis (EM) (8/47, 17%) were the most common associated clinical phenotypes. The most frequently associated neural antibodies (Abs) were voltage-gated calcium channel (VGCC)-Abs (14/45, 31%), followed by Hu-Abs (8/45, 17%) and neurofilament (NF)-Abs (8/45, 17%). Patients with NF-Abs only exhibited CNS disorders (8/8, 100%) and often had antibodies against >1 NF subunit (6/8, 75%). At onset, 26 of 43 patients (60%) had no identifiable primary skin tumor but had lymph node metastasis; these patients were more frequently men (21/26, 80%, vs 7/17, 41%; p = 0.007), had more frequently VGCC-Abs (12/26, 46%, vs 2/17, 11%, p = 0.02) predominantly among those with LEMS, and presented reduced mortality than patients with a known primary tumor (5/25, 20%, vs 8/15, 53%; p = 0.02).

Discussion

MCC-related PNSs present as a heterogeneous clinical spectrum including central and/or peripheral nervous system disorders such as LEMS, RCPS, and EM, mainly associated with VGCC-Abs, NF-Abs, and Hu-Abs. NF-Abs were only seen among patients with CNS disorders. At onset, the absence of a primary skin tumor but presence of lymph node metastasis is frequently observed, and this particular clinical presentation is linked to reduced mortality, highlighting distinctive clinical and immunologic features of MCC-related PNS.

Suggestions

Du même auteur

Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis

Archive ouverte | Ciano-Petersen, Nicolás Lundahl | CCSD

International audience. Background and Objectives Anti-NMDA receptor (NMDAR) encephalitis is defined by the presence of antibodies (Abs) targeting the NMDAR in the CSF. This study aimed to determine the prognostic v...

Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis

Archive ouverte | Ciano-Petersen, Nicolás Lundahl | CCSD

International audience

Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis

Archive ouverte | Ciano-Petersen, Nicolás Lundahl | CCSD

Autoimmune encephalitides constitute a diverse group of immune-mediated central nervous system disorders mainly characterized by the presence of antibodies targeting neuronal or glial antigens. Despite the notable contribution of ...

Chargement des enrichissements...